carfilzomib

navigate by keyword : carfilzomib carfilzomibe cancer anticancer tumor antitumoral proteasome inhibitor tetrapeptide epoxomycin epoxomicin multiple myeloma cfz kahler plasma cell myelomatosis carbon hydrogen oxygen nitrogen disease drug therapy medicine medicinal product pharmacology pharmacy pharmaceutical pharma treatment generic molecule atoms chemical chemistry composition atomic model molecular

Carfilzomib (CFZ) multiple myeloma cancer drug molecule. Proteasome inhibitor derived from natural product epoxomicin Royalty Free Stock Photo
Carfilzomib (CFZ) multiple myeloma cancer drug molecule. Proteasome inhibitor derived from natural product epoxomicin Royalty Free Stock Photo
Carfilzomib CFZ multiple myeloma cancer drug molecule. Proteasome inhibitor derived from natural product epoxomicin. Skeletal. Royalty Free Stock Photo
Carfilzomib CFZ multiple myeloma cancer drug molecule. Proteasome inhibitor derived from natural product epoxomicin. Skeletal. Royalty Free Stock Photo
Multiple myeloma. Close-up of Abnormal plasma cells, red blood cells, and antibodies Royalty Free Stock Photo
   
   
Carfilzomib (CFZ) multiple myeloma cancer drug molecule. Proteasome inhibitor derived from natural product epoxomicin
Multiple myeloma in the bone marrow. Histology. Royalty Free Stock Photo
Multiple myeloma in the bone marrow. Histology. Royalty Free Stock Photo
   
   
   
Multiple myeloma in the bone marrow. Histology. Royalty Free Stock Photo
Multiple myeloma in the bone marrow. Histology. Royalty Free Stock Photo
Carfilzomib (CFZ) multiple myeloma cancer drug molecule. Proteasome inhibitor derived from natural product epoxomicin. Atoms are represented as spheres with conventional color coding: hydrogen (white), carbon (grey), oxygen (red), nitrogen (blue


Stockphotos.ro (c) 2025. All stock photos are provided by Dreamstime and are copyrighted by their respective owners.